Related Experiment Video
Updated: Jan 22, 2026
07:41
Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
3.4K
Small animal models of heart failure
Christian Riehle1, Johann Bauersachs1
1Department of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, Germany.
Cardiovascular Research
|June 28, 2019
Summary
Small animal models are crucial for understanding heart failure (HF) mechanisms and developing new treatments. This review examines their strengths and limitations to advance cardiovascular disease therapies.
Area of Science:
- Cardiovascular Research
- Translational Medicine
- Animal Models
Background:
- Heart disease is a leading global cause of mortality with rising prevalence.
- Developing novel therapeutic strategies for heart failure (HF) is a critical medical need.
- Small animal models are essential tools for studying HF pathogenesis.
Purpose of the Study:
- To review the strengths and limitations of commonly used small animal models of heart failure.
- To highlight the contribution of these models to understanding HF.
- To inform the development of future therapeutic strategies for HF.
Main Methods:
- Review of existing literature on small animal models for heart failure.
- Analysis of models utilizing surgical, genetic, and pharmacological approaches.
- Discussion of the advantages and disadvantages of various models.
Main Results:
- Small animal models have significantly advanced the understanding of HF.
- These models employ diverse techniques to replicate HF conditions.
- Despite limitations, they remain vital for preclinical research.
Conclusions:
- Small animal models are indispensable for advancing HF research and treatment development.
- Critical evaluation of model strengths and limitations is necessary for effective translation.
- Continued use and refinement of these models will drive therapeutic innovation for heart disease.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
790
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
790
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:27Heart Failure I: Introduction
729
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
729
01:22Heart Failure VI: Adjunct Therapies
278
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
278
01:22Heart Failure Drugs: Diuretics
825
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
825
01:30Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227